Hartmann Young, an international search company that specialises in biotechnology and the life sciences, is moving to new larger headquarters in Leeds as it looks to double the size of its workforce in 2022.

The company is moving to new 3000 sq ft headquarters in Toronto Square Leeds as it doubled its staff numbers to over 25 specialist consultants in the last 12 months.

Hartmann Young expects to recruit another 25 consultants in 2022 to support its continued growth, focusing on overseas markets to support its operations in the biotechnology hubs of Boston and California.

Commenting on the growth, Andrew Buxton, CEO said: “Our growth over the last 12 months has been staggering. We’ve built a strong international reputation in the biotechnology and life sciences sectors thanks to our collaborative and team-focused approach.”

“We utilise our broad experience and specialist, global network to offer our clients a turnkey solution to their talent acquisition and retention plans. Our investment in training and technology mean we add real value to the recruitment process, with clients regarding us as a true partner to help fuel their rapid or strategic growth plans.”

Hartmann Young offers consultants state-of-the-art offices, extended lunch breaks and unlimited holidays for personal health and wellbeing, alongside a technology package that includes the latest Apple equipment and leading software.

Consultants at Hartmann Young undergo extensive training to give them an in-depth understanding of the relevant industry sector, resulting in a team that has a broad range of sector-specific knowledge to enable them to select the highest quality candidates for their clients. In addition, the company benchmarks salaries in its sector to offer market-leading compensation packages and operates a four and a half day week.

The global biotechnology market was estimated at USD 752.88 billion in 2020 and is expected to reach USD 1,006.68 billion in 2021. The UK BioIndustry Association (BIA) estimates that UK biotech companies raised a record £2.8 billion in equity finance in 2020. The UK is considered to be the third global life sciences cluster, rivalling San Francisco and Boston, Massachusetts, and is home to 6,300 life science companies.

Andrew concluded: “Our clients include some of the industry’s leading companies and most innovative start-ups globally, so international expansion is an essential step in our ambitions. Leeds will become our headquarters and international centre of excellence as we build a global network of offices to serve our expanding client base. It means our consultants have the opportunity for unparalleled earning potential and the opportunity to work in one of the world’s most innovative industries.”